| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |